1.
Bonita R, Beaglehole R, Kjellström T, World Health Organization, Ebooks Corporation Limited. Basic epidemiology [Internet]. 2nd edition. Geneva: World Health Organization; 2006. Available from: https://ebookcentral.proquest.com/lib/gla/detail.action?docID=284799
2.
Rose G. Strategy of prevention : lessons from cardiovascular disease. BMJ. BMJ; 1981;282(6279):1847–1851.
3.
Hart J. Measurement of omission. BMJ. BMJ; 1982;284(6330):1686–1689.
4.
Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. The Lancet. 2012 Jul;380(9836):37–43.
5.
Ezzati M, Obermeyer Z, Tzoulaki I, Mayosi BM, Elliott P, Leon DA. Contributions of risk factors and medical care to cardiovascular mortality trends. Nature Reviews Cardiology. 2015 Jun 16;12(9):508–530.
6.
Richards H, Reid M, Watt G. Socio-economic variations in responses to chest pain : a qualitative study. BMJ. BMJ; 2002;324(7349):1308–1310.
7.
Jackson R, Wells S, Rodgers A. Will screening individuals at high risk of cardiovascular events deliver large benefits? Yes. BMJ. 2008 Aug 28;337(aug28 2):a1371–a1371.
8.
Capewell S. Will screening individuals at high risk of cardiovascular events deliver large benefits? No. BMJ. 2008 Aug 28;337(aug28 2):a1395–a1395.
9.
Capewell S, Graham H. Will Cardiovascular Disease Prevention Widen Health Inequalities? PLoS Medicine. 2010 Aug 24;7(8).
10.
Reckless JPD. Primary prevention of cardiovascular disease. BMJ. 2011 Jan 25;342(jan25 4):d201–d201.
11.
Hingorani AD, Hemingway H. How should we balance individual and population benefits of statins for preventing cardiovascular disease? BMJ. 2010 Jan 26;342(jan26 1):c6244–c6244.
12.
Khunti K, Walker N, Sattar N, Davies M. Unanswered questions over NHS health checks. BMJ. 2010 Feb 1;342(jan26 1):c6312–c6312.
13.
O’Donnell CA, Mackenzie M, Reid M, Turner F, Clark J, Wang Y, Sridharan S, Platt S. Delivering a national programme of anticipatory care in primary care: a qualitative study. British Journal of General Practice. 2012 Apr 1;62(597):288–296.
14.
Linardakis M, Smpokos E, Papadaki A, Komininos I, Tzanakis N, Philalithis A. Prevalence of multiple behavioral risk factor for chronic diseases in adults aged 50+, from eleven European countries – the SHARE study (2004). Preventive Medicine; 57 (3):168–172. Available from: https://ezproxy.lib.gla.ac.uk/login?url=https://www.sciencedirect.com/science/article/pii/S0091743513001539
15.
Prochazka AV, Caverly T. General Health Checks in Adults for Reducing Morbidity and Mortality From Disease. JAMA Internal Medicine. 2013 Mar 11;173(5).
16.
Artac M, Dalton A, Majeed A, Car J, Millett C. Effectiveness of a national cardiovascular disease risk assessment program (NHS Health Check): Results after one year. Preventive Medicine; 2013;57 (2):129–134. Available from: https://ezproxy.lib.gla.ac.uk/login?url=https://www.sciencedirect.com/science/article/pii/S0091743513001473
17.
World Health Organization pages on Cardiovascular Disease [Internet]. Available from: http://www.who.int/cardiovascular_diseases/en/
18.
WHO Factsheet No 317 on Cardiovascular Diseases (CVDs) – updated January 2015. [Internet]. Available from: http://www.who.int/mediacentre/factsheets/fs317/en/
19.
WHO Global Atlas on CVD Prevention and Control [Internet]. Available from: http://www.who.int/cardiovascular_diseases/publications/atlas_cvd/en/
20.
WHO Global Status Report on Noncommunicable Diseases 2014 [Internet]. Available from: http://apps.who.int/iris/bitstream/10665/148114/1/9789241564854_eng.pdf?ua=1
21.
Cleland J, Dargie H, Hardman S, McDonagh T, Mitchell P. National heart failure audit. April 2012-March 2013 [Internet]. National Institute for Cardiovascular Outcomes Research (NICOR); 2013. Available from: http://www.wales.nhs.uk/sitesplus/documents/862/National%20Heart%20Failure%20Audit%20April%202012-March2013.pdf#:~:text=6%20National%20Heart%20Failure%20Audit%20April%202012-March%202013,the%202011%2F12%20cohort.%20This%20improvement%20reflects%20better%20treatment
22.
Acute heart failure: diagnosis and management (NICE guidelines [CG187]). National Institute for Health and Care Excellence; Available from: https://www.nice.org.uk/guidance/cg187
23.
Chronic heart failure in adults: management (NICE guidelines [CG108]) [Internet]. National Institute for Health and Clinical Excellence; Available from: http://www.nice.org.uk/guidance/cg108
24.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GMC, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal. 2016 Jul 14;37(27):2129–2200.
25.
McAlister FA, Stewart S, Ferrua S, McMurray JJJV. Multidisciplinary strategies for the management of heart failure patients at high risk for admission. Journal of the American College of Cardiology. 2004 Aug;44(4):810–819.
26.
Sochalski J, Jaarsma T, Krumholz HM, Laramee A, McMurray JJV, Naylor MD, Rich MW, Riegel B, Stewart S. What Works In Chronic Care Management: The Case Of Heart Failure. Health Affairs. 2009 Jan 1;28(1):179–189.
27.
McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure. New England Journal of Medicine. 2014 Sep 11;371(11):993–1004.
28.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 Aug 8;136(6):e137–e161.
29.
Cleland J. The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe Part 1: patient characteristics and diagnosis. European Heart Journal. 2003 Mar;24(5):442–463.
30.
SIGN 147: Management of chronic heart failure. A national clinical guideline. [Internet]. Scottish Intercollegiate Guidelines Network, Healthcare Improvement Scotland; 2016. Available from: http://www.sign.ac.uk/assets/sign147.pdf
31.
Ezekowitz JA, O’Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth S, Al-Hesayen A, Cohen-Solal A, D’Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B. 2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure. Canadian Journal of Cardiology. 2017 Nov;33(11):1342–1433.
32.
Baron-Franco B, McLean G, Mair FS, Roger VL, Guthrie B, Mercer SW. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care. British Journal of General Practice. 2017 May;67(658):e314–e320.
33.
Royal College of Physicians of Edinburgh Consensus Statement on Atrial Fibrillation [Internet]. 2012. Available from: https://www.rcpe.ac.uk/sites/default/files/files/final_statement.pdf
34.
National clinical guidelines centre. Atrial fibrillation: The management of atrial fibrillation [Internet]. NICE; 2014. Available from: https://www.nice.org.uk/guidance/cg180
35.
European society of cardiology. Atrial Fibrillation 2016 (Management of) ESC Clinical Practice Guidelines [Internet]. European society of cardiology; 2016. Available from: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Atrial-Fibrillation-Management
36.
Heidbuchel H, Verhamme P, Alings M, Antz M, Diener HC, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof P. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace. 2015 Oct;17(10):1467–1507.
37.
Jani BD, Nicholl BI, McQueenie R, Connelly DT, Hanlon P, Gallacher KI, Lee D, Mair FS. Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort. EP Europace. 2017 Nov 2;
38.
Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, Pepi M, Pezawas T, Granell RR, Sarasin F, Ungar A, van Dijk JG, Walma EP, Wieling W, Abe H, Benditt DG, Decker WW, Grubb BP, Kaufmann H, Morillo C, Olshansky B, Parry SW, Sheldon R, Shen WK, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, McGregor K, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas P, Widimsky P, Auricchio A, Acarturk E, Andreotti F. Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). European Heart Journal. 2009 Nov 1;30(21):2631–2671.
39.
National Institute for Health and Care Excellence (NICE). Transient loss of consciousness ('blackouts’) management in adults and young people [Internet]. Available from: https://www.nice.org.uk/guidance/cg109
40.
Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Thomsen PEB, van Dijk JG, Fitzpatrick A, Hohnloser S, Janousek J, Kapoor W, Kenny RA, Kulakowski P, Masotti G, Moya A, Raviele A, Sutton R, Theodorakis G, Ungar A, Wieling W. Guidelines on management (diagnosis and treatment) of syncope – Update 2004. European Heart Journal. 2004 Nov;25(22):2054–2072.
41.
Kabat H, Anderson JP. Acute Arrest of Cerebral Circulation in Man. Archives of Neurology & Psychiatry. 1943 Nov 1;50(5):510–528.
42.
Determining driver fitness in Canada [Internet]. Canadian council of motor transport administrators; Available from: https://www.transportation.alberta.ca/content/docType45/Production/CCMTADriverMedicalStandardsAugust2013.pdf
43.
Scottish Intercollegiate Guidelines Network (SIGN). Cardiac arrhythmias in coronary heart disease [Internet]. Edinburgh: SIGN; 2018. Available from: https://www.sign.ac.uk/assets/sign152.pdf
44.
CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. The Lancet. 2015 Jun;385(9985):2383–2391.
45.
Douglas PS, Hoffmann U, Patel MR, Mark DB, Al-Khalidi HR, Cavanaugh B, Cole J, Dolor RJ, Fordyce CB, Huang M, Khan MA, Kosinski AS, Krucoff MW, Malhotra V, Picard MH, Udelson JE, Velazquez EJ, Yow E, Cooper LS, Lee KL. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease. New England Journal of Medicine. 2015 Apr 2;372(14):1291–1300.
46.
European Society of Cardiology. Stable Coronary Artery Disease (Management of) ESC Clinical Practice Guidelines [Internet]. European Heart Journal. European Society of Cardiology; 2013. Available from: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Stable-Coronary-Artery-Disease-Management-of
47.
SIGN 96 Scottish Intercollegiate Guidelines Network. management of stable angina [Internet]. Available from: http://www.sign.ac.uk/pdf/sign96.pdf
48.
Angina - NICE CKS [Internet]. Available from: https://cks.nice.org.uk/angina
49.
Scottish Intercollegiate Guidelines Network (SIGN). Management of stable angina [Internet]. Edinburgh: SIGN; 2018. Available from: https://www.sign.ac.uk/sign-151-stable-angina
50.
Gan Y, Gong Y, Tong X, Sun H, Cong Y, Dong X, Wang Y, Xu X, Yin X, Deng J, Li L, Cao S, Lu Z. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry. 2014;14(1).
51.
Thombs BD, Bass EB, Ford DE, Stewart KJ, Tsilidis KK, Patel U, Fauerbach JA, Bush DE, Ziegelstein RC. Prevalence of depression in survivors of acute myocardial infarction. Journal of General Internal Medicine. 2006 Jan;21(1):30–38.
52.
Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L. Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations: A Scientific Statement From the American Heart Association. Circulation. 2014 Mar 25;129(12):1350–1369.
53.
Meijer A, Conradi HJ, Bos EH, Thombs BD, van Melle JP, de Jonge P. Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. General Hospital Psychiatry. 2011 May;33(3):203–216.
54.
Hare DL, Toukhsati SR, Johansson P, Jaarsma T. Depression and cardiovascular disease: a clinical review. European Heart Journal. 2014 Jun 1;35(21):1365–1372.
55.
Meijer A, Zuidersma M, de Jonge P. Depression as a non-causal variable risk marker in coronary heart disease. BMC Medicine. 2013;11(1).
56.
Thombs BD, Roseman M, Coyne JC, de Jonge P, Delisle VC, Arthurs E, Levis B, Ziegelstein RC. Does Evidence Support the American Heart Association’s Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review. PLoS ONE. 2013 Jan 7;8(1).
57.
Whooley MA, P de J, E V, C O, R M, R M C, S A, S D, B N, M D F, N B S, W S B. Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease. JAMA. 2008 Nov 26;300(20).
58.
Poole L, Dickens C, Steptoe A. The puzzle of depression and acute coronary syndrome: Reviewing the role of acute inflammation. Journal of Psychosomatic Research. 2011 Aug;71(2):61–68.
59.
Harris P, Sommargren C, Stein P, Fung G, Drew B. Heart rate variability measurement and clinical depression in acute coronary syndrome patients: narrative review of recent literature. Neuropsychiatric Disease and Treatment. 2014 Jul;
60.
R von K. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence? Acta Psychiatr Scand. 2004 Sep 1;110.
61.
Jokinen J, Nordström P. HPA axis hyperactivity and cardiovascular mortality in mood disorder inpatients. Journal of Affective Disorders. 2009 Jul;116(1–2):88–92.
62.
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 1996. Available from: https://ezproxy.lib.gla.ac.uk/login?url=https://doi.wiley.com/10.1002/14651858.CD008012.pub3
63.
Tully PJ, Baumeister H. Collaborative care for comorbid depression and coronary heart disease: a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 2015 Dec;5(12).
64.
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GYH, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal. 2012 Jul 2;33(14):1787–1847.
65.
Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. European Journal of Heart Failure; 2009 May;11(5):433–443.
66.
End of life care in heart failure. A framework for implementation [Internet]. NHW Improving Quality; 2014. Available from: http://www.nhsiq.nhs.uk/media/2574509/end-of-life-care-in-heart-failure-framework-for-implementation.pdf
67.
Living and dying well: a national action plan for palliative care and end of life care in Scotland [Internet]. The Scottish Government; 2008. Available from: http://www.palliativecarescotland.org.uk/content/publications/living-and-dying-well.pdf
68.
Living and dying with advanced heart failure: a palliative care approach [Internet]. The Scottish Government; 2008. Available from: http://www.palliativecarescotland.org.uk/content/publications/HF-final-document.pdf
69.
Hogg KJ, Jenkins SMM. Prognostication or identification of palliative needs in advanced heart failure: where should the focus lie? Heart. Heart; 2012 Apr 1;98(7):523–524.
70.
Johnson M, Beattie J, Hogg K, Watson MS. Heart failure: from advanced disease to bereavement. Oxford: Oxford University Press; 2012.
71.
Browne S, Macdonald S, May CR, Macleod U, Mair FS. Patient, Carer and Professional Perspectives on Barriers and Facilitators to Quality Care in Advanced Heart Failure. PLoS ONE. PLos One; 2014 Mar 27;9(3).
72.
Pettit SJ, Browne S, Hogg KJ, Connelly DT, Gardner RS, May CR, Macleod U, Mair FS. ICDs in end-stage heart failure. BMJ Supportive & Palliative Care. BMJ Supportive and Palliative Care; 2012 Jun 1;2(2):94–97.
73.
Fang JC, Ewald GA, Allen LA, Butler J, Westlake Canary CA, Colvin-Adams M, Dickinson MG, Levy P, Stough WG, Sweitzer NK, Teerlink JR, Whellan DJ, Albert NM, Krishnamani R, Rich MW, Walsh MN, Bonnell MR, Carson PE, Chan MC, Dries DL, Hernandez AF, Hershberger RE, Katz SD, Moore S, Rodgers JE, Rogers JG, Vest AR, Givertz MM. Advanced (Stage D) Heart Failure: A Statement From the Heart Failure Society of America Guidelines Committee. Journal of Cardiac Failure. Journal of Cardiac Failure; 2015 Jun;21(6):519–534.
74.
Cowie MR, Bax J, Bruining N, Cleland JGF, Koehler F, Malik M, Pinto F, van der Velde E, Vardas P. e-Health: a position statement of the European Society of Cardiology. European Heart Journal. 2016 Jan 1;37(1):63–66.
75.
Widmer RJ, Collins NM, Collins CS, West CP, Lerman LO, Lerman A. Digital Health Interventions for the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings [Internet]. 2015 Apr;90(4):469–480. Available from: https://ezproxy.lib.gla.ac.uk/login?url=https://link.galegroup.com/apps/doc/A411614975/AONE?u=glasuni&sid=AONE&xid=0e272c31
76.
Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, Stewart S, Cleland JG. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database of Systematic Reviews [Internet]. Chichester, UK: John Wiley & Sons, Ltd; 1996 Sep 1; Available from: https://ezproxy.lib.gla.ac.uk/login/?url=https://doi.wiley.com/10.1002/14651858.CD007228.pub2
77.
Frederix I, Hansen D, Coninx K, Vandervoort P, Vandijck D, Hens N, Van Craenenbroeck E, Van Driessche N, Dendale P. Medium-Term Effectiveness of a Comprehensive Internet-Based and Patient-Specific Telerehabilitation Program With Text Messaging Support for Cardiac Patients: Randomized Controlled Trial. Journal of Medical Internet Research. 2015 Jul 23;17(7).
78.
E-Health Strategy 2011-2017 [Internet]. The Scottish Government and NHS Scotland; Available from: http://www.scotland.gov.uk/Publications/2011/09/09103110/0
79.
Murray E, Burns J, May C, Finch T, O’Donnell C, Wallace P, Mair F. Why is it difficult to implement e-health initiatives? A qualitative study. Implementation Science. 2011;6(1).
80.
Mair FS, May C, O’Donnell C, Finch T, Sullivan F, Murray E. Factors that promote or inhibit the implementation of e-health systems: an explanatory systematic review. Bulletin of the World Health Organization. 2012 May 1;90(5):357–364.
81.
Burke LE, Ma J, Azar KMJ, Bennett GG, Peterson ED, Zheng Y, Riley W, Stephens J, Shah SH, Suffoletto B, Turan TN, Spring B, Steinberger J, Quinn CC. Current Science on Consumer Use of Mobile Health for Cardiovascular Disease Prevention. Circulation. 2015 Sep 22;132(12):1157–1213.
82.
O’Connor S, Hanlon P, O’Donnell CA, Garcia S, Glanville J, Mair FS. Understanding factors affecting patient and public engagement and recruitment to digital health interventions: a systematic review of qualitative studies. BMC Medical Informatics and Decision Making. 2016 Dec;16(1).
83.
Lennon MR, Bouamrane MM, Devlin AM, O’Connor S, O’Donnell C, Chetty U, Agbakoba R, Bikker A, Grieve E, Finch T, Watson N, Wyke S, Mair FS. Readiness for Delivering Digital Health at Scale: Lessons From a Longitudinal Qualitative Evaluation of a National Digital Health Innovation Program in the United Kingdom. Journal of Medical Internet Research. 2017 Feb 16;19(2).
84.
Mair FS, May CR. Thinking about the burden of treatment. BMJ. 2014 Nov 10;349(nov10 4):g6680–g6680.
85.
May C, Montori VM, Mair FS. We need minimally disruptive medicine. BMJ. British Medical Journal; 2009 Aug 11;339(aug11 2):b2803–b2803.
86.
Abu Dabrh AM, Gallacher K, Boehmer KR, I.G. H, F.S. M. Minimally disruptive medicine: the evidence and conceptual progress supporting a new era of healthcare. Journal of the Royal College of Physicians of Edinburgh [Internet]. Journal of the Royal College of Physicians of Edinburgh; 2015;45(2):114–117. Available from: http://www.rcpe.ac.uk/sites/default/files/mair.pdf
87.
Shippee ND, Allen SV, Leppin AL, May CR, Montori VM. Attaining minimally disruptive medicine: context, challenges and a roadmap for implementation. Journal of the Royal College of Physicians of Edinburgh [Internet]. Journal of the Royal College of Physicians of Edinburgh; 2015;45(2):118–122. Available from: https://www.rcpe.ac.uk/sites/default/files/shippee.pdf
88.
Gallacher K, May CR, Montori VM, Mair FS. Understanding Patients’ Experiences of Treatment Burden in Chronic Heart Failure Using Normalization Process Theory. The Annals of Family Medicine. 2011 May 1;9(3):235–243.
89.
Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. Journal of Clinical Epidemiology. 2012 Oct;65(10):1041–1051.
90.
May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, Mair FS, May CM, Montori VM, Richardson A, Rogers AE, Shippee N. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness. BMC Health Services Research. 2014;14(1).
91.
Jani B, Blane D, Browne S, Montori V, May C, Shippee N, Mair FS. Identifying treatment burden as an important concept for end of life care in those with advanced heart failure. Current Opinion in Supportive and Palliative Care. 2013 Mar;7(1):3–7.
92.
Gallacher K, Morrison D, Jani B, Macdonald S, May CR, Montori VM, Erwin PJ, Batty GD, Eton DT, Langhorne P, Mair FS. Uncovering Treatment Burden as a Key Concept for Stroke Care: A Systematic Review of Qualitative Research. PLoS Medicine. 2013 Jun 25;10(6).
